During the past decade, Institute for Cancer Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Cancer Research" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Cancer Research" are "Breast Cancer" (2 trials) and "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Institute for Cancer Research" in a lesser frequency.

Most popular intervention types in "Institute for Cancer Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Cancer Research" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Institute for Cancer Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute for Cancer Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Cancer Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".